PubMed · 2014 · 14 citations · 40 references
MedicineOncologyPharmacologyCancer Drug Toxicity ManagementChemotherapyOncology PharmacotherapyNeurotoxicity ManagementToxicity ManagementColon Cancer Adjuvant TherapyIntravenous Chemotherapy DosingNeurotoxicityOff-label Drug ToxicityOncology Chemotherapy DosingWashout Periods
Oral dichloroacetate sodium (DCA) is currently under investigation as a single agent and as an adjuvant for treatment of various cancers. One of the factors limiting its clinical use in a continuous oral regimen is a dose-related, reversible neurotoxicity, including peripheral neuropathy and encephalopathy. The intravenous (IV) route has a number of potential advantages, including (1) pulsed dosing to achieve higher concentrations than feasible with oral use, (2) a longer washout period to reduce the potential for neurotoxicity, and (3) a bypassing of the digestive system, which is particularly significant for advanced-stage cancer patients. Data were available on high-dose IV DCA (up to 100 mg/kg/dose) that have confirmed its safety, both in healthy volunteers and in critically ill patients, allowing the authors to begin off-label treatment of cancer patients. In several of their patients treated with IV DCA, the authors observed clinical, hematological, or radiological responses. This article presents 3 cases with patients who had recurrent cancers and for whom all conventional therapies had failed: (1) a 79-y-old male patient with colon cancer who had liver metastases, (2) a 43-y-old male patient with angiosarcoma who had pancreatic and bone metastases, and (3) a 10-y-old male patient with pancreatic neuroendocrine carcinoma who had liver metastases.
40
Treatment of symptomatic diabetic peripheral neuropathy with the anti-oxidant ?-lipoic acid
Dan Ziegler, M Hanefeld, K. J. Ruhnau et al. · Diabetologia · 1995 · 526 citations · Full text
Medicine, Neurology, Pharmacology +12
Dichloroacetate causes toxic neuropathy in MELAS
P. Kaufmann, Kristin Engelstad, Ying Wei et al. · Neurology · 2006 · 362 citations
Medicine, Neurology, Pharmacology +13
Jessemae L. Welsh, Brett A. Wagner, Thomas J. van ‘t Erve et al. · Cancer Chemotherapy and Pharmacology · 2013 · 302 citations · Full text
Medicine, Oncology, Pharmacology +14